Friday, May 11, 2012

PLPL strongest under .50 the last month...bullish report today

Renewed upside continues.......Remains on ongoing strength focus...
Notice breaking near term resistance at .35
Prior we made comments this one could take off....



Recall 13mil financing earlier in week....Pretty strong vote of confidence....
Plandai Chairman and Chief Executive Officer, Roger Duffield, commented, "Closing this loan is a significant milestone for Plandai because it provides us with the capital necessary to move immediately into production of our highly bioavailable Green Tea extract without causing any dilution to our shareholders
.......We have already contracted with our USA engineering partner, CRS Technologies Inc. Delaware, to commence the manufacture of our first hydrodynamic processing and extraction system, in order that we can begin the first commercial, bioavailable Green Tea catechin extract production by the end of the year. At the same time, we have begun work on our Senteeko tea estate to make sure there is suitable and adequate green tea crop available in the last quarter 2012.
About Plandai Biotechnology, Inc.
Plandai Biotechnology, Inc. focuses on the farming of whole fruits, vegetables and live plant material and the production of proprietary functional foods and botanical extracts for the health and wellness industry. Its principle holdings consist of land, farms and infrastructure in South Africa. Web site: http://us.lrd.yahoo.com/_ylt=Ao3xSK7LSj1ZpSBkLbWO.b6duodG;_ylu=X3oDMTFuaXBiczg4BG1pdANBcnRpY2xlIEJvZHkEcG9zAzQEc2VjA01lZGlhQXJ0aWNsZUJvZHlUZW1wQXNzZW1ibHk-;_ylg=X3oDMTJuYjM3bjFjBGludGwDdXMEbGFuZwNlbi11cwRwc3RhaWQDZDAwODc5NTQtZDEyMi0zZjhjLWI1ZTQtOGFkMWI1NWRhZWM1BHBzdGNhdANuZXdzBHB0A3N0b3J5cGFnZQ--;_ylv=0/SIG=11iqkr20c/EXP=1337962274/**http://www.plandaibiotech.com/
Recall earlier from nbt weekly

Monday, May 7, 2012

Strong Growth Microcaps on the move / OTCBB under 1 / Pinksheets / Turnaround /: PLPL ramping into .30s...has seen ongoing strength...

Strong Growth Microcaps on the move / OTCBB under 1 / Pinksheets / Turnaround /: PLPL ramping into .30s...has seen ongoing strength...: Focus mentions are actually best strength from prior newsletter mentions at Greenbackers. Considerable added risk, however LUXR...

PLPL ramping into .30s...has seen ongoing strength last month plus

Focus mentions are actually best strength from prior newsletter mentions at Greenbackers.
Considerable added risk, however LUXR doesn't want to quit yet
Recent Quotes
SymbolPriceChange% ChgChart
1.89+0.19+11.18%undefined
PLPL new round of ramping developing..?.....Monitor on volume pickup as well...........general ongoing strength in last month plus from .15 recall......recent basing in upper .20s...

Plandai Biotechnology, Inc. (PLPL.OB)

-OTC BB
Recall friday pickup with PLPL following NBT rpt.....growing impact....
Dear friend of NBT,
NBT starts coverage on Plandai Biotechnology, Inc. (PLPL) with Speculative Buy  $2.50 target because they are about to bring a super high dosage (i.e. up to 8X the “good stuff” in your body from ONE serving) green tea extract to the $50 billion global tea market. We have followed Plandai’s quest for many years, and are excited to announce they are NOW less than a year away from the holy grail of green tea—60-80% bioavailable/absorbable green tea extract.
Our PLPL Executive Summary Report is in final stages and will be out in a few days…but I wanted to get this quick alert to you today because the shares are starting to gain traction.
But first…really…does anyone reading this NOT like Green Tea? Does anyone want to consume 8-10 16 oz. bottles of Green Tea every day to get the health benefits …not so much.
What if you could get 800% or 8X MORE of the incredible antioxidants and other benefits from just ONE 16 oz. green tea beverage or 2 liquid gel caps?
That is the value proposition of the Plandai’s breakthrough technology for harvesting and processing live green tea plants into the 8X as absorbable super tea extract we call “BioTea”. PLPL is just days away from closing the $13 million development loan from South Africa’s Land Bank that kicks off rapid development of the world’s next major tea plantation (the tea estates in Limpopo region of South Africa).
After 10 years of blood, sweat, research and heartache, in our opinion PLPL is about to become an “overnight success.”
We will outline all the facts to support our investment thesis in our complete research report. Tea is the second most consumed beverage is the world behind water…and with PLPL’s breakthrough in creating a 8S more bioavailable green tea extract, consuming tea made for Plandai’s BioTea extract is about to become one of the healthiest things a person can do for their health maintenance.
Now…before you answer the question about your interest in an 8X as powerful green tea (BioTea), read what Mitsui Norin, one of the largest manufacturer of high dosage green tea extract cites as the 12 major health benefits of absorbing large amounts of green tea “catechins” into your body every day (Gallate catechins are the good stuff…the active ingredient in green tea)
1. Anti-oxidative and anti-aging effects
2. Immune system enhancing effects
3. Bad breath prevention and deodorant
4. Anti-microbial effects and cold prevention
5. Controlling high blood sugar levels
6. Probiotic effects
7. Controlling high blood pressure
8. Prevention of tooth decay
9. Controlling cholesterol
10. Weight management
11. Enhances DNA integrity
12. Anti-allergic effect
To actual GET these benefits from green tea catechins, you need to be able to ABSORB these nutrients as you consume them. The problem is today’s green tea extract features less than <2% absorption in humans…NOT enough to derive the amazing amount of health benefits.
The solution? After 10 years of research and testing, PLPL is about to build the manufacturing facility within its tea estate in Limpopo South Africa that will create thousands of kilos of BioTea extract every month. Tea extract that because of its special processing allows you to absorb 60-80% of MORE of the catechins INTO YOUR BODY…i.e. enough for you to actual GET the amazing health benefits of green tea.
In short: Plandai’s BioTea is a complete game changer in the $50 billion global tea industry. We strongly encourage you to pick up some shares at this LOW valuation (their tea estate properties ALONE appraise at over $50 million in latest appraisal). This time NEXT year as their Plandai BioTea hits the market it will be a whole new ball game for the stock value in our opinion.
PS—when I told our client Pulse Beverage (PLSB) about the properties of Plandai’s BioTea, Bob Yates the CEO said “If you don’t get me the rights to BioTea in North America you are FIRED—do your realize that BioTea is a complete game changer for the MASSIVE $5-$6 billion tea beverage industry just in North America.”
I have promised Pulse Beverage the first shot at making a Super Tea from Plandai’s BioTea ultra-high dosage green tea extract…does that make Pulse the second derivative play on BioTea?




Thursday, April 26, 2012

Focus on turnaround bias with VELA.....noteworthy report on GLYE..The next Waste Management

 
Forwarding input from http://www.greenbackers.com/ morning newslettters 4/26
 
 
Some input from Tobin Smith worth noting

Vela big news...just VN alone is a .10 a share vale as they are in very successful trials with ALL the major wireless carriers in China and ex Chairman of ZTE is the CEO...with power brown outs daily in major cities and new 4G antenaes starting to roll out its a $100 million opportunity...

More to come

 
 
 
 
 
 
Recall prior comments
 
VELA turnaround yesterday.....Could continue to see rebuilding w/news
 
China's Ministry of Industry and Information Technology has granted approval of VN Tech's hydrogen fuel cells for use in telecommunications base transceiver stations (BTS)....
 
 
 
Although down, still to consider for developing a higher low.....catalyst for fueling turnaround into May..
 


Volume:1,208,000
 
 
 
 
Focus:
 
 
 
 
 
 
2-3
 
 
Recall REPCF upcoming cure for baldness fda review next week.....has been steadily gaining from 2 this week....Continue to target upper 2s ahead of review.....
 
 
 
REPCF.OB10:17am EDT2.53Up 0.13Up 5.42%14,814
 
 
 
 
 
 
Pennies:
 
 
PLPL observing consolidation following recent run from .20....
PLPL.OB10:02am EDT0.2520Down 0.0320Down 11.27%28,726
 
 
 
 
VELA jumped earlier to .026....focus on flatline support/higher low moving forward..
 
 
 
 
MSLP.OB10:26am EDT0.0173Down 0.0021Down 10.82%4,815,575
 
 
 
WBSI increasing upside mentions....Dips back in .04 range observe, given recent technicals...
WBSI.OB10:28am EDT0.0510Up 0.0060Up 13.33%7,303,304
Wednesdays news:
 

 
 
 
 
 
 
 
 
 
 
---
 
Initial Buy GLYE Strong Buy $8.50 $22 Long Term 12X Upside
NBT Equities Research has initiated coverage on GlyEco, Inc., (GLYE) a glycol waste management & recycling technology company that has initiated a MAJOR consolidation play for the leading glycol recycling companies in North America. We start coverage with a Strong Buy $8.50 2013 target at 22X .40 EPS @55 million shares (fully diluted) and long term 2015 $22.50 Target based on DCF model of $60MM 2015 EBITDA  or 12X Upside from the current $1.90 price-per-share. They are currently in silent period during an equity raise.
We think we have found the NEXT $Billion Waste Management/Republic Industries consolidator in America. Waste Management (WM) was the first and Republic Industries (RSG) the second. Both of these companies made their founders $billionaires and early investors millionaires many, many times over.
For many reasons, we think GLYE is the next $Billion market cap company in waste management—but this time investors get a GREEN or CLEANTECH company that has actual economics and PROFITS...who would have of thought you can BE green and MAKE green (given the Solyndra’s of the world.) We will publish our full NBT Research Report early next week but I wanted to get you the gist of our investment thesis today.
So guess what—there is a market based solution to glycol recycling with ZERO government loans that we figure can generate a $Billion or more in shareholder value...
...but THIS time you and I get a chance to invest our hard earned emerging growth capital at the beginning of the consolidation cycle as if we were buying early shares like the Waste Management (WM) and Republic Industries (RSG) investors in the 80’s and 90’s.
Who says there is no time machine for growth investors?
Note: I have followed glycol recycling since we started to research my last book “Billion Green” on Cleantech/Green Investing. What attracted me so much to the recycling glycol idea was:
A)     There is a HUGE amount of very toxic glycol in the world to recycle—5 billion gallons worldwide and 700 million gallons in the US every year.

B)     Virtually EVERY country in the world MANDATES recovery and recycling—glycol is a very hazardous liquid chemical that KILLS most everything it is exposed to.

C)     There is MANDATED use of recycled glycol in most State and Federal governments, including the military and HUGE demand for “green” recycled anti-freeze products in transportation fleets and for retail auto owners who prefer to purchase recycled products for their car like oil or anti-freeze.

D)     As such there is MORE DEMAND than supply—always a good thing in building a profitable business.
The ONE thing missing from this cottage industry (hundreds of small local recyclers) was
A)     Technology to turn old glycol into Type 1 quality “virgin” glycol—i.e., the “good stuff” that is worth $500+ per barrel.

B)     A significant enough amount of Type 1 recycled glycol to meet North American and world demand.

C)     Somebody to put the whole enchilada together to get to the critical mass of recycled Type 1 glycol necessary to meet North American and worldwide demand.
Well THAT is the value proposition of GlyEco—their patent-pending GlyEco Technology takes all kinds of glycol feedstock and turns the vast majority of that feedstock to ASTM Type 1 recycled glycol ready to be turned into
1)      Recycled plastic containers
2)      Polyester Fabrics
3)      Recycled Antifreeze
4)      Glycol concentrate for a whole host of applications
Now add in the consolidator business model and John Lorenz. Mr. Lorenz is 30 year veteran of solid waste industry and this GLYE play is NOT his first consolidation rodeo. He founded Environmental Waste of America—now Waste Management. Early investors in Waste Management made literally millions on their initial investments... John has ONE more waste consolidation company in him and GLYE is it!
Add a very deep team with 67 years of waste management and glycol recycling industry experience, patent pending technology that revolutionizes the entire $3.5 billion US glycol recycling industry...and combine the top 12-14 players under ONE GLYE roof and you have the GLYE strategy down cold.
Just the United States consolidation and recycling technology upgrades alone gets GLYE to .40 EPS in the first year—and they are 1/3 of the way to their 12 acquisition target as of today.
By 2015 they are at @$70 million gross revenues domestic--$45 million NET revenues from International partners...and somewhere north of $60 million EBIDTA. Put an 8X EBITDA value on this and we are half way to $1 billion market cap.
Now think international—a market that is 7X the US market. GLYE has plans to by 2016 have international revenues in EXCESS of US—and 100% of that international revenue is PURE PROFIT—a 12.5% licensing fee from partners all over the world. By 2016 international NET profits—GlyEco’s 12.5% NET royalty on international recycler partners using the GlyEco system—almost DOUBLE the GROSS revenues of North America (according to the Investor Presentation they 8k’d last week).
Put EVERYTHING together in a bow and GLYE is a first: an extremely profitable Cleantech company with GREAT private market economics and NO government subsidies or loans—just mandates that glycol users DON’T DUMP toxic glycol in our rivers, streams, lakes and dumps.
In our opinion, GLYE IS the next $Billion Cleantech company...and the FIRST one to get theirs the old fashioned way...WITHOUT tax credits or government loans!
Halleluiah—strongly encourage you to pick up shares UNDER $2.50 and HOLD EM. Check out their website at glyeco.com.

GLYE.OB10:17am EDT1.97Up 0.05Up 2.60%1,875


 
 
 
 
http://www.greenbackers.com/ is an established, nationally recognized Microcap related Stock Market Website, that specializes in profiling emerging/rapidly growing companies, and putting them in front of thousands of active investors.  Greenbackers has over 15 years of experience getting the word out with small and micro cap sectors of investing. 
 
 
 

Tuesday, April 24, 2012

XCLL chart of interest... two higher lows....Re-examinng bullish forecast earlier in April...Exploding Mach5 sales

Focus:
 
 
Increasingly attracted to XCLL for turnaround.....
XCLL.OB11:29am EDT0.47Up 0.0150Up 3.30%509,157
 
May want to re-examine earlier in month article....
  • XcelMobility Mach 5 Enabled USB Modems Experiencing Strong SalesMarketwire(Tue, Apr 10)
  •  
    Best strength from prior mentions:
     
    RACK up 4fold....
    RACK.OB11:35am EDT1.650.47+39.83%375,975
     
    LUXR keeps going....
    LUXR.PK11:39am EDT1.320.18+15.79%1,701,422
     
     
     
     
    REPCF seeing a slight pickup....Expect increasing volatility in 2 range into announcement....
    REPCF.OB10:23AM 2.13Up 0.07Up 3.40%38,585
    Analyzer earlier this morning on the stock: 
     
    Replicel Life Sciences, Inc. (REPCF)  6 trading days till announcement-RE: first human Phase I/IIa trial results data on what some are suggesting is the first real cure for hair loss in men and women.

    Replicel's patented hair follicle cell replication and implantation technology is designed to not only initiate natural hair regeneration but also rejuvenate existing dormant hair follicles in patients suffering from male and female pattern baldness.
    http://nbtequitiesresearch.com/sites/default/files/uploads/20111204_NBT_EQUITY_GROUP_REPLICEL_LIFE_SCIENCE_REPORT.pdf
     
     


     
     
     
     
     
    Pennies:
     
    PLPL new mention....
    PLPL.OB11:38am EDT0.2450Up 0.0350Up 16.67%35,607
     
     

     Prior mentioned to examine MSLP closely below .02.....Investors doing just that
    MSLP.OB10:30am EDT0.0195-0.00-11.36%18,147,611
    Muscle Pharm Corp. (MSLP.OB)
    Recall drop on yesterdays upbeat news...
    the first order of Mach 5 enhanced high speed USB modems shipped to China Unicom retail locations across the country have experienced strong sales and excellent feedback from users..... Should initial trials continue to prove successful, ZTE has projected that in the future up to 30 million units per year could be installed with the Mach 5 Xcelerator......(ceo) We are enthusiastically predicting sales to continue to remain strong and to expand rapidly
     
     
    Notice two higher lows

     
    Chart forXcelMobility Inc. (XCLL.OB)